BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010
|
US Biomax |
|
160.00€ |
|
Pub |
BC03013 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723
|
US Biomax |
|
160.00€ |
|
Pub |
BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014
|
US Biomax |
|
160.00€ |
|
Pub |
BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808
|
US Biomax |
|
231.00€ |
|
Pub |
LV802 |
Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801
|
US Biomax |
|
189.00€ |
|
Pub |
BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015
|
US Biomax |
|
160.00€ |
|
Pub |
BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803
|
US Biomax |
|
160.00€ |
|
Pub |
BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013
|
US Biomax |
|
160.00€ |
|
Pub |
BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807
|
US Biomax |
|
231.00€ |
|
Pub |
BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728
|
US Biomax |
|
160.00€ |
|
Pub |
BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721
|
US Biomax |
|
160.00€ |
|
Pub |
BC12012 |
Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802
|
US Biomax |
|
231.00€ |
|
Pub |
BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160.00€ |
|
Pub |
LC1004 |
Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
LC801 |
Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BC04015 |
Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189.00€ |
|
Pub |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
ST802 |
Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO802 |
Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801
|
US Biomax |
|
189.00€ |
|
Pub |
BC19013 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC05012 |
Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores.
|
US Biomax |
|
231.00€ |
|
Pub |
BC07014 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC02012 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC09012 |
Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC803 |
Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue array
|
US Biomax |
|
231.00€ |
|
Pub |
BC04012 |
Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803
|
US Biomax |
|
231.00€ |
|
Pub |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81.00€ |
|
Pub |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BN03011 |
Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801
|
US Biomax |
|
160.00€ |
|
Pub |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PA721 |
Pancreatic carcinoma (multi tissue combined panel), 24 cases 72 cores, replacing BC14012
|
US Biomax |
|
231.00€ |
|
Pub |
BC00116 |
Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T034 |
Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
429.00€ |
|
Pub |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
LV1502 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
BC24011 |
Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801
|
US Biomax |
|
160.00€ |
|
Pub |
SO751 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723
|
US Biomax |
|
160.00€ |
|
Pub |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
ON481 |
Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BN01011 |
Normal stomach tissue (multi sites) array, 21 cases 63 cores, replaced by BN01011b
|
US Biomax |
|
160.00€ |
|
Pub |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809
|
US Biomax |
|
160.00€ |
|
Pub |
NHL802a |
Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T205 |
Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
UT961 |
Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BS08011 |
Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727
|
US Biomax |
|
160.00€ |
|
Pub |
CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
PRF281 |
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed
|
US Biomax |
|
742.35€ |
|
Pub |
BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.
|
US Biomax |
|
456.00€ |
|
Pub |
LC961 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BC050112 |
Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726
|
US Biomax |
|
231.00€ |
|
Pub |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296.00€ |
|
Pub |
BN05011 |
Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014
|
US Biomax |
|
160.00€ |
|
Pub |
T141a |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T176 |
Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO488 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
UT1501 |
Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
CR601 |
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602
|
US Biomax |
|
231.00€ |
|
Pub |
T214 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
RE1021 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BN07012 |
Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803
|
US Biomax |
|
160.00€ |
|
Pub |
FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
BCN801 |
Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T046 |
Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
NHL401a |
Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
SK245 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BC04016 |
Lung carcinoma tissue array, 72 cases 72 cores, replaced by LC726
|
US Biomax |
|
160.00€ |
|
Pub |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
811.00€ |
|
Pub |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed
|
US Biomax |
|
382.00€ |
|
Pub |
TH802a |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804
|
US Biomax |
|
231.00€ |
|
Pub |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores
|
US Biomax |
|
278.00€ |
|
Pub |
BN04011 |
Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725
|
US Biomax |
|
160.00€ |
|
Pub |
FMC281 |
Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723
|
US Biomax |
|
160.00€ |
|
Pub |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FDA999a |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BC19017 |
Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809
|
US Biomax |
|
160.00€ |
|
Pub |
T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T144 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FRA781-2 |
FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
UT243 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
MO541 |
Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T244 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429.00€ |
|
Pub |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed
|
US Biomax |
|
429.00€ |
|
Pub |
OV961 |
Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BS03011 |
Hepatocellular carcinoma tissue array, 21 cases 63 cores, replaced by LV804
|
US Biomax |
|
160.00€ |
|
Pub |
CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T203a |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
KD1501 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
UT802 |
Uteral cancer (multi types of uterine carcinomas and diseases) tissue array, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
TH242 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BR1001 |
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T125 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T388 |
Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PR802 |
Prostate carcinoma tissue array, 80 cases 80 cores, no overlaps with PR801, replaced by PR8010
|
US Biomax |
|
231.00€ |
|
Pub |
IC03001 |
Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805
|
US Biomax |
|
231.00€ |
|
Pub |
BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
ST1004 |
Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR1004 |
Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010
|
US Biomax |
|
314.00€ |
|
Pub |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95
|
US Biomax |
|
456.00€ |
|
Pub |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246
|
US Biomax |
|
88.00€ |
|
Pub |
FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a
|
US Biomax |
|
293.00€ |
|
Pub |
PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FRA781-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807
|
US Biomax |
|
160.00€ |
|
Pub |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
RE1503 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
VLC12 |
Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
GL806a |
Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014
|
US Biomax |
|
231.00€ |
|
Pub |
T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed
|
US Biomax |
|
742.00€ |
|
Pub |
FRA901a |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
278.00€ |
|
Pub |
ES1201 |
Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202
|
US Biomax |
|
278.00€ |
|
Pub |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
GI961 |
GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724
|
US Biomax |
|
160.00€ |
|
Pub |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
MBN481 |
Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160.00€ |
|
Pub |
FBN407a |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
LC488 |
Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
LC1502 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601
|
US Biomax |
|
278.00€ |
|
Pub |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702
|
US Biomax |
|
231.00€ |
|
Pub |
T343 |
Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
ST962 |
Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
LVC2281 |
Liver cancer high density tissue array, 228 cases 228 cores, replaced by LV2161
|
US Biomax |
|
403.00€ |
|
Pub |
CO1002 |
Colon and rectum carcinoma and normal tissue array, 73 cases 100 cores, replaced by CO1002b
|
US Biomax |
|
278.00€ |
|
Pub |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BC06022 |
Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by RE722
|
US Biomax |
|
160.00€ |
|
Pub |
T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC01071 |
Carcinoma of stomach, liver and rectum tissue array, 45 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
SF961 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808
|
US Biomax |
|
160.00€ |
|
Pub |
IC00011 |
Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases 80 cores, replaced by IC00011b
|
US Biomax |
|
231.00€ |
|
Pub |
BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011
|
US Biomax |
|
231.00€ |
|
Pub |
LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LV1501 |
Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
ST1503 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
SK961 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483
|
US Biomax |
|
160.00€ |
|
Pub |
BC00014 |
Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631
|
US Biomax |
|
160.00€ |
|
Pub |
BR802 |
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases 80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b
|
US Biomax |
|
231.00€ |
|
Pub |
LV243 |
Liver cancer tissue array with normal tissues from autopsy, 12 cases 24 cores, with grade and stage
|
US Biomax |
|
88.00€ |
|
Pub |
MC242 |
Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245
|
US Biomax |
|
88.00€ |
|
Pub |
CR1001 |
Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429.00€ |
|
Pub |
KD811 |
Renal carcinoma and normal tissue array, with TNM, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FMC406 |
Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963
|
US Biomax |
|
231.00€ |
|
Pub |
LC641 |
Non small cell lung carcinoma (NSCLC) tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
NHL481 |
Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482
|
US Biomax |
|
189.00€ |
|
Pub |
LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088
|
US Biomax |
|
88.00€ |
|
Pub |
LVC1502 |
Liver cancer mid density tissue array, non overlapping with LVC1501 or LVC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BS05041 |
Colon adenocarcinoma (grade III) tissue array, 23 cases 63 cores, replaced by CO725
|
US Biomax |
|
189.00€ |
|
Pub |
LV2081 |
Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 cores
|
US Biomax |
|
516.00€ |
|
Pub |
LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information
|
US Biomax |
|
456.00€ |
|
Pub |
GL805 |
Glioblastoma multiforme (GBM) tissue array, 40 cases 80 cores, replaced by GL806
|
US Biomax |
|
266.00€ |
|
Pub |
MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964
|
US Biomax |
|
231.00€ |
|
Pub |
BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a
|
US Biomax |
|
88.00€ |
|
Pub |
KD481 |
Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR243 |
Breast cancer and adjacent normal tissue array, 6 cases 24 cores, replaced by BR243a
|
US Biomax |
|
88.00€ |
|
Pub |
LV483 |
Multiple liver cancer tissue array with normal tissue control from autopsy, with TNM data, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
CyFDA1 |
FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T385 |
Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386
|
US Biomax |
|
88.00€ |
|
Pub |
LC481 |
Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
SO802 |
Malignant fibrohistiocytoma tissue array, 80 cases 80 cores; ihc CD68 confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
278.00€ |
|
Pub |
LV803 |
Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021
|
US Biomax |
|
231.00€ |
|
Pub |
PR801 |
Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases 80 cores, replaced by PR803
|
US Biomax |
|
231.00€ |
|
Pub |
BC08023 |
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC1005 |
Lung carcinoma progression tissue array, 77 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
SK801 |
Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b
|
US Biomax |
|
278.00€ |
|
Pub |
BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax |
|
231.00€ |
|
Pub |
LVC962 |
Liver cancer and normal tissue array, non overlapping with LVC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
PR954 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR955
|
US Biomax |
|
456.00€ |
|
Pub |
LV2083 |
High density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LV2088 |
Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin
|
US Biomax |
|
114.00€ |
|
Pub |
KD486 |
Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR809 |
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
FBN406a |
Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
LV6161 |
High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
LV808 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores
|
US Biomax |
|
321.00€ |
|
Pub |
LC802 |
Lung small cell carcinoma tissue array (40 cases 80 cores)
|
US Biomax |
|
266.00€ |
|
Pub |
LV1201 |
Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
397.00€ |
|
Pub |
NPC961 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC962, >50 cases 96 cores
|
US Biomax |
|
344.00€ |
|
Pub |
PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802
|
US Biomax |
|
231.00€ |
|
Pub |
FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997
|
US Biomax |
|
278.00€ |
|
Pub |
ME1001 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266.00€ |
|
Pub |
BS36011 |
Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases 75 cores, replaced by OS803
|
US Biomax |
|
266.00€ |
|
Pub |
ESC242 |
Esophagus cancer tissue array, 12 cases 24 cores; ihc H&E, IHC anti-Cytokeratin
|
US Biomax |
|
205.00€ |
|
Pub |
LV242 |
Multiple Liver cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
OV1001 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005
|
US Biomax |
|
231.00€ |
|
Pub |
LM802 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
MC241 |
Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244
|
US Biomax |
|
88.00€ |
|
Pub |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456.00€ |
|
Pub |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011
|
US Biomax |
|
231.00€ |
|
Pub |
BS02021 |
Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores
|
US Biomax |
|
321.00€ |
|
Pub |
MC541 |
Multiple organ, diseased tissue array (54 cases 54 cores, 18 types of cancers), replaced by MC542
|
US Biomax |
|
160.00€ |
|
Pub |
BC02023 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722
|
US Biomax |
|
160.00€ |
|
Pub |
LVC1501 |
Liver cancer mid density tissue array, non overlapping with LVC1502 or LVC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BS05031 |
Colon adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by CO724
|
US Biomax |
|
160.00€ |
|
Pub |
LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011
|
US Biomax |
|
231.00€ |
|
Pub |
ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801
|
US Biomax |
|
231.00€ |
|
Pub |
LV208 |
Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade info
|
US Biomax |
|
456.00€ |
|
Pub |
OM601 |
Metastatic carcinoma of epiploon tissue array, 60 cases 60 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC001111 |
Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601
|
US Biomax |
|
231.00€ |
|
Pub |
SM801 |
Small intestine carcinoma and normal tissue array, 77 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR242 |
Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores, replaced by BR244
|
US Biomax |
|
88.00€ |
|
Pub |
T032 |
Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
LV482 |
Multiple liver cancer tissue array with 4 normal tissues control from autopsy, with TNM, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
PR241 |
Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243
|
US Biomax |
|
88.00€ |
|
Pub |
BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503
|
US Biomax |
|
278.00€ |
|
Pub |
BN113 |
Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores
|
US Biomax |
|
189.00€ |
|
Pub |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
BS03013 |
Hepatocellular carcinoma tissue array, 22 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax |
|
160.00€ |
|
Pub |
NHL802 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL801, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
BRM481 |
Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
FRA901a-2 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c
|
US Biomax |
|
626.00€ |
|
Pub |
MO03011 |
Mouse liver tissue array, 100 cases 100 cores, 50 male and 50 female
|
US Biomax |
|
160.00€ |
|
Pub |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266.00€ |
|
Pub |
UT803 |
Endometrioid carcinoma, adjacent and normal tissue array, with grade and stage information, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LVC961 |
Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BS06041 |
Rectum adenocarcinoma (grade III) tissue array, 21 cases 63 cores, replaced by RE724
|
US Biomax |
|
160.00€ |
|
Pub |
PR953 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR954
|
US Biomax |
|
456.00€ |
|
Pub |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
LV2082 |
Liver cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC951 |
Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax |
|
336.00€ |
|
Pub |
LV2087 |
Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
BR808 |
Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018
|
US Biomax |
|
231.00€ |
|
Pub |
BC30011 |
Heart tissue array, 13 cases 34 cores, replaced by BC30013
|
US Biomax |
|
231.00€ |
|
Pub |
T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044
|
US Biomax |
|
88.00€ |
|
Pub |
BR1921 |
High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T391 |
Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T392
|
US Biomax |
|
88.00€ |
|
Pub |
ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
LP803 |
Laryngeal squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
FMO901-2 |
Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
PA207 |
High density (69 cases 207 cores), multiple pancreatic cancer (1 3 grade) and normal pancreatic tissue array, replaced by PA2072
|
US Biomax |
|
456.00€ |
|
Pub |
LV807 |
Liver cancer and normal tissue array with TNM and grade, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231.00€ |
|
Pub |
LV1003 |
Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
314.00€ |
|
Pub |
NPC481 |
Nasopharyngeal carcinoma tissue array, 48 cases 49 cores
|
US Biomax |
|
189.00€ |
|
Pub |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
MO1601 |
Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011
|
US Biomax |
|
278.00€ |
|
Pub |
CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014
|
US Biomax |
|
231.00€ |
|
Pub |
FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995
|
US Biomax |
|
314.00€ |
|
Pub |
BS26011 |
Osteosarcoma tissue array, 32 cases 63 cores, replaced by OS804
|
US Biomax |
|
231.00€ |
|
Pub |
LV241 |
Liver cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC00119 |
Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483
|
US Biomax |
|
160.00€ |
|
Pub |
BN07011 |
Normal kidney tissue array (multi sites), 20 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FMC405 |
Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a
|
US Biomax |
|
88.00€ |
|
Pub |
LV801 |
Liver cancer tissue array, with matched or unmatched adjacent normal tissue, 75 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BS01042 |
Stomach adenocarcinoma (grade III) tissue array, 22 cases 63 cores, replaced by ST723
|
US Biomax |
|
160.00€ |
|
Pub |
PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores
|
US Biomax |
|
266.00€ |
|
Pub |
BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores
|
US Biomax |
|
558.00€ |
|
Pub |
BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T194 |
Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88.00€ |
|
Pub |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PA241 |
Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b
|
US Biomax |
|
100.00€ |
|
Pub |
LVC1021 |
Liver cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BS05021 |
Colon adenocarcinoma (grade I) tissue array, 23 cases 63 cores, replaced by CO723
|
US Biomax |
|
160.00€ |
|
Pub |
LV2001 |
High density liver cancer tissue array, paraffin section, 200 cases 200 cores
|
US Biomax |
|
397.00€ |
|
Pub |
LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC00012 |
Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801
|
US Biomax |
|
160.00€ |
|
Pub |
BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FFE302a |
Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
T031 |
Liver cancer test tissue array with normal liver tissues, with TNM, stage and grade info, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
LV481 |
Liver cancer tissue array with normal adjacent tissues, 23 cases 48 cores, with grade and stage data
|
US Biomax |
|
160.00€ |
|
Pub |
MCN601 |
Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602
|
US Biomax |
|
231.00€ |
|
Pub |
LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
T171 |
Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases 24 cores, replaced by T174
|
US Biomax |
|
88.00€ |
|
Pub |
CO482 |
Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
LV8013 |
Hepatocellular carcinoma tissue array, including TNM, pathology grade, HBV and HCV infection information, 40 cases 80 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861
|
US Biomax |
|
266.00€ |
|
Pub |
BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
LC1002 |
Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013
|
US Biomax |
|
231.00€ |
|
Pub |
FRA901a-1 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c
|
US Biomax |
|
626.00€ |
|
Pub |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806
|
US Biomax |
|
266.00€ |
|
Pub |
LVC482 |
Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC481, 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BS06031 |
Rectum adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by RE723
|
US Biomax |
|
160.00€ |
|
Pub |
PR952 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953
|
US Biomax |
|
314.00€ |
|
Pub |
LV20812 |
Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
LV2086 |
Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC2082 |
Multiple lung carcinoma and normal tissue array, 70 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR807 |
Medullary carcinoma of breast tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV486 |
Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
|
US Biomax |
|
296.00€ |
|
Pub |
BR486 |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LV806 |
Liver hemangiomas tissue array with normal tissue control from autopsy, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BS04041 |
Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV1002 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
NPC111 |
Nasopharyngeal carcinoma tissue array, 11 cases 11 cores
|
US Biomax |
|
106.00€ |
|
Pub |
OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011
|
US Biomax |
|
231.00€ |
|
Pub |
BS17015 |
Brain glioma tissue array, 63 cases 63 cores, replaced by GL803
|
US Biomax |
|
231.00€ |
|
Pub |
BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
BC19015 |
Prostate carcinoma tissue array, 9 cases 27 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LV2161 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456.00€ |
|
Pub |
KD802 |
Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BN06012 |
Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013
|
US Biomax |
|
231.00€ |
|
Pub |
LC501 |
Tissue array of multi type lung cancer and normal tissue with TNM and grade, 50 cases 50 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
SK243 |
Age grouped female skin tissue array, 12 cases 24 cores, replaced by SK244
|
US Biomax |
|
231.00€ |
|
Pub |
BR701 |
Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962
|
US Biomax |
|
231.00€ |
|
Pub |
T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084
|
US Biomax |
|
88.00€ |
|
Pub |
LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax |
|
231.00€ |
|
Pub |
LV1921 |
Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LC1921 |
High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MO32011 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replaced by MO1002
|
US Biomax |
|
189.00€ |
|
Pub |
CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
OV951 |
Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores,
|
US Biomax |
|
456.00€ |
|
Pub |
LV245 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax |
|
266.00€ |
|
Pub |
T381 |
Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385
|
US Biomax |
|
88.00€ |
|
Pub |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
LV8012 |
Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
SK483 |
Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LVC481 |
Liver cancer and normal tissue array, non overlapping with LVC482, 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax |
|
321.00€ |
|
Pub |
LV20811 |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LV2085 |
Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PE801 |
Penile (penis) carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BN01013 |
Normal stomach tissue (multi sites) array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LY802 |
Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LV485 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax |
|
397.00€ |
|
Pub |
BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BN116 |
Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129
|
US Biomax |
|
189.00€ |
|
Pub |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2
|
US Biomax |
|
278.00€ |
|
Pub |
LV805 |
Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001
|
US Biomax |
|
231.00€ |
|
Pub |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120
|
US Biomax |
|
278.00€ |
|
Pub |
CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax |
|
321.00€ |
|
Pub |
BO243 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244
|
US Biomax |
|
88.00€ |
|
Pub |
SK802 |
Skin squamous cell carcinoma (SCC) tissue array, 80 cases 80 cores, no overlaps with SK801
|
US Biomax |
|
231.00€ |
|
Pub |
BR8010 |
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BS17011 |
Brain glioblastoma tissue array, 21 cases 63 cores, replaced by GL811
|
US Biomax |
|
231.00€ |
|
Pub |
PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir
|
US Biomax |
|
487.00€ |
|
Pub |
FDA998 |
FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999
|
US Biomax |
|
314.00€ |
|
Pub |
ME1003 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004
|
US Biomax |
|
266.00€ |
|
Pub |
BS17018 |
Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722
|
US Biomax |
|
231.00€ |
|
Pub |
BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802
|
US Biomax |
|
231.00€ |
|
Pub |
BN06011 |
Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245
|
US Biomax |
|
88.00€ |
|
Pub |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b
|
US Biomax |
|
88.00€ |
|
Pub |
LV721 |
Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |